Cogent Biosciences, Inc.

Cogent Biosciences, Inc.

COGT
Cogent Biosciences, Inc.US flagNASDAQ Global Select
32.26
USD
-0.50
- -
5.51BMarket Cap

Cogent Biosciences, Inc. (COGT) Stock Splits

Learn about Cogent Biosciences, Inc.'s most recent 1-for-4 basis stock split on November 09, 2020. Understand the impact on shareholders and the company's market position.

Latest Stock Split Details

Key information about Cogent Biosciences, Inc.'s most recent stock split

Split Date: 2020-11-09
Split Ratio: 1:4
Price Before Split: $2.51
Price After Split: $0.63

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 4.00 times fewer shares (a 1:4 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Cogent Biosciences, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2020-11-091:4Yes$2.51$0.63

About Cogent Biosciences, Inc.

Company overview and industry information

Cogent Biosciences, Inc. (COGT) operates in the Biotechnology industry. The recent 1-for-4 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Cogent Biosciences, Inc. Summary

Last updated: 6/4/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.

COGT Stock Splits — Cogent Biosciences, Inc. | Roic AI